Cite

HARVARD Citation

    Lake, J. et al. (n.d.). Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial1. HIV medicine. 15 (7), pp. 431-441. [Online]. 
  
Back to record